🟢 Novavax is trading 5% up today as broad risk appetite lifts U.S. equities

Novavax is trading 5.09% up at $10.62 as broad risk appetite lifts U.S. equities on September 21, 2026.

• The S&P 500, Nasdaq Composite, and Dow Jones are all higher; easing oil prices and Treasury yields are supporting sentiment.
• No clear company-specific announcement was identified for September 21; recent coverage centers on Novavax’s partnership-led model and policy developments.
• The move appears primarily global, with technology and growth stocks leading the market rebound.